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Available online 28 December 2016Immobilization of nanoparticles on inorganic supports has been recently developed, resulting in the creation of
nanocomposites. Concerning titanium dioxide nanoparticles (TiO2 NPs
1), these have already been developed in
conjugation with clays, but so far there are no available toxicological studies on these nanocomposites. The pres-
ent work intended to evaluate the hepatic toxicity of nanocomposites (C-TiO22), constituted by rutile TiO2 NPs
immobilized in nanokaolin (NK3) clay, and its individual components.
These nanomaterials were analysed by means of FE-SEM4 and DLS5 analysis for physicochemical characteriza-
tion. HepG2 cells were exposed to rutile TiO2 NPs, NK clay and C-TiO2 nanocomposite, in the presence and
absence of serum for different exposure periods. Possible interferences with the methodological procedures
were determined for MTT,6 neutral red uptake, alamar blue (AB), LDH,7 and comet assays, for all studied
nanomaterials. Results showed that MTT, AB and alkaline comet assay were suitable for toxicity analysis of the
present materials after slight modiﬁcations to the protocol. Signiﬁcant decreases in cell viability were observed
after exposure to all studied nanomaterials. Furthermore, an increase in HepG2 DNA damage was observed
after shorter periods of exposure in the absence of serum proteins and longer periods of exposure in their
presence. Although the immobilization of nanoparticles in micron-sized supports could, in theory, decrease the
toxicity of single nanoparticles, the selection of a suitable support is essential. The present results suggest that
NK clay is not the appropriate substrate to decrease TiO2 NPs toxicity. Therefore, for future studies, it is critical
to select a more appropriate substrate for the immobilization of TiO2 NPs.













zolium Bromide assay1. Introduction
Nanotechnology is growing at an increasingly rapid pace in the past
years, revealing innovative and attractive nanomaterials with speciﬁc
properties for several applications (Savolainen et al., 2013). Within the
existing nanomaterials, themost used are themetal oxide nanoparticles
(Djurisic et al., 2014), being titanium dioxide nanoparticles (TiO2 NPs)
the most extensively studied (both in concern to material characteriza-
tion and toxic properties) due to their economic interest and unique
properties, including large surface area, high stability, anticorrosive,
ultra-violet (UV) absorption, whitening and opacifying characteristics
and photocatalytic activity (Menard et al., 2011). Titanium dioxide is
obtained from the iron mineral ilmenite, a naturally occurring crystal
that can exist in three major crystalline forms (rutile, anatase and
brookite) (Iavicoli et al., 2011; Park et al., 2014), but only rutile and
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applications (Iavicoli et al., 2011; Becker et al., 2014). Textile industries,
biotechnology, pharmaceutical and cosmetics are prominent areas of
TiO2 NPs applications, leading to the increasing worldwide distribution
of these nanoparticles (Gupta and Tripathi, 2011; Botelho et al., 2014).
Due to the unavoidable presence of TiO2 NPs, their toxicity have been
widely studied; however, in the literature, the results have been contra-
dictory (Iavicoli et al., 2012; Shi et al., 2013). For some researchers, TiO2
NPs are considered to be a nontoxic mineral, being even used as nega-
tive control inmany in vitro and in vivo studies (Liu et al., 2013). Despite
that, others investigators demonstrate opposite effects. Onemain prob-
lematic associated with engineered nanoparticles such as TiO2 NPs is
that these materials can across the cell membrane, especially into the
mitochondria, causing organelle dysfunction (Teodoro et al., 2011). Sev-
eral authors suggests that TiO2NPsmay induce higher toxicity potential,
including the impairment of mitochondrial function, decrease of cell vi-
ability and proliferation, and an increase of oxidative stress leading to
genotoxic effects and apoptotic events (Freyre-Fonseca et al., 2011;
Iavicoli et al., 2011; Jaeger et al., 2012).
Owing to the distinctive properties derived by the nano-sized
particles, some reports demonstrate that nanoparticles are more toxic
when compared to larger micron-sized particles (Kocbek et al., 2010;
Roy et al., 2014). This enhances the importance of an innovative area
of nanotechnology: nanoarchitectonics. Nanoarchitectonics is a tech-
nology system which enables assembling nanostructure units into
novel structure functionality through mutual interactions among units
(Aono et al., 2012). This ﬁeld of nanomaterials introduced innovations
in the design and constructions systems in nanoelectronics,
nanomachinery, energy conversion, andmore recently in nanomedicine
(Gonzalez-Alfaro et al., 2011; Kujawa and Winnik, 2013).
Recent advances lead to the development of new nanocomposites,
namely nanoparticles immobilized in inorganic or organic substrates
that, by presenting new physico-chemical features, must be tested
with regards to their toxicological potential (Aono et al., 2012). It
has been considered that immobilization with proper mineral
nanomaterials is a good strategy to diminish the possible release of
these nanoparticles into the environment, facilitating their manipula-
tion (Tokarčíková et al., 2014). Concerning TiO2 NPs, these have already
been developed in conjugation with modiﬁed clays minerals, but to our
knowledge there are no earlier toxicological studies on these novel
nanocomposites (Manova et al., 2010).
In this context, the main goal of the present work was to evaluate in
vitro cytotoxicity and genotoxicity of a nanocomposite (herein desig-
nated as C-TiO2) constituted by rutile TiO2 NPs and high purity
nanokaolin (NK) clay in a hepatocellular carcinoma human cell line
(HepG2). For a matter of comparison, both TiO2 and NK single particles
were also studied.2. Materials and methods
2.1. Chemicals
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), neutral red dye, resazurin, Triton X-100, 2-mercaptoethanol,
low melting point (LMP) agarose, Tris hydrochloride (Tris-HCl) and
methyl methanesulfonate (MMS) were purchased from Sigma-Aldrich
Co. Dimethyl sulfoxide (DMSO), glacial acetic acid (CH3COOH), absolute
ethanol (C2H6O), sodium hydroxide (NaOH), sodium chloride (NaCl)
and potassium hydroxide (KOH) were bought from Merck KGaA. Cell
culture media components and SyberGold® were all Invitrogen™ and
purchased from Thermo Fisher Scientiﬁc Inc. Lactate dehydrogenase
(LDH) protein from rabbit muscle and Tris base were purchased from
Calbiochem, while potassium chloride (KCl) and disodium salt
dihydrate (Na2EDTA) were purchased from Prolab. Finally, high purity
2-(4-Iodphenyl)-3-(4-nitrophenyl)-5-phenyltetrazoliumchlorid (INT)and normal melting point (NMP) agarose were supplied from VWR
chemicals, Lonza Group AG and Bioline, respectively.
2.2. Nanomaterial preparation
The nanomaterials under study were rutile nanoparticles (NM-104,
UE Joint ResearchCentre, Institute forHealth and Consumer Protection),
high purity kaolin nanoclay (Nanobiomatter Industries S.L.) and rutile
nanoparticles immobilized in high purity kaolin nanoclay. The rutile
TiO2 NPswere dispersed and anchored onNK clay to formnanocompos-
ite, C-TiO2, following the method patented by Fernandez et al. (2010),
presenting 10% of rutile TiO2 NPs and 90% of NK clay.
All studied nanomaterials were suspended in serum-free and com-
plete HepG2 cell culture media (300 μg/mL for TiO2 NPs, 2700 μg/mL
for NK clay and 3000 μg/mL for C-TiO2 nanocomposite). Afterwards,
the suspensions were homogenized in a microﬂuidizer (Model LM10,
Microﬂuidics International Corporation) at 12500 Psi, for three times.
This procedure was performed in an interaction chamber with Y geom-
etry (single-slotted) with suspensions placed in an ice-water bath.
Prior to each toxicity treatment and interference analysis,
nanomaterials suspensions were sonicated in water bath for 5 min. Se-
rial dilutions were carried out to obtain the different nanomaterial con-
centrations tested and sonicated in water bath for 5 additional minutes
prior to testing.
2.3. Nanomaterial characterization
Primary particle size, size distribution and particlemorphologywere
characterized by Field-Emission Scanning Electron Microscopy (FE-
SEM)with a 1.5 nm resolution, working at 20 kVwith a current intensi-
ty of 10 μA (Model S-4700, Hitachi Ltd. Corporation). Information on
size distribution was calculated frommeasuring at least 100 nanoparti-
cles in random ﬁelds of view.
Average hydrodynamic size, zeta potential andpolydisperse index of
suspensionsweremeasured by DLS using a Zetasizer Nano-ZS equipped
with 4.0 mW, 633 nm laser (Model ZEN 3600, Malvern Instruments
Ltd.). For this evaluation, the nanomaterials suspensions were diluted
to a 0.01 μg/mL concentration.
2.4. Cell culture
Hepatocellular carcinoma human cell line (HepG2) was obtained
from the European Collection of Authenticated Cell Cultures (ECACC)
and cultured in nutrient mixture DMEM (Dulbecco's modiﬁed Eagle's
medium)mediumwith L-Glutamine (2mM), antibiotic and antimycotic
solution (100 units/mL of penicillin, 100 μg/mL of streptomycin and
0.25 μg/mL of amphotericin), supplemented with 10% heat-inactivated
fetal bovine serum (FBS).
Cells were incubated in a humidiﬁed atmosphere with 5% CO2 at
37 °C. To carry out the experiments, 3 × 104 cells were seeded in 96-
well plates and 2 × 105 cells in 24-well plates for the cytotoxic and
genotoxic evaluation, respectively, and allowed to adhere for 24 h at
37 °C. For cell treatments, thesewere incubated at 37 °C for different pe-
riods in the presence of the different nanomaterial concentrations, or
control solutions.
2.5. Exposure conditions
For each cytotoxic assay, nanomaterial and type of cell culturemedia
(complete and serum-free), 6 different concentrations of each
nanomaterial (5, 25, 50, 100, 200 and 300 μg/mL for TiO2 NPs; 45, 225,
445, 900, 1800 and 2700 μg/mL for NK clay and 50, 250, 500, 1000,
2000 and 3000 μg/mL for C-TiO2 nanocomposite), in addition to a nega-
tive and a positive control, and 3 exposure periods (3, 6, and 24 h)were
evaluated. Complete or serum-free media was used as negative control
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itive control.
For genotoxic assessment, 3 non-cytotoxic concentrations of each
nanomaterial were tested (5, 25 and 50 μg/mL for TiO2 NPs; 45, 225
and 445 μg/mL for NK clay and 50, 250 and 500 μg/mL for C-TiO2 nano-
composite) in both complete and serum-free media, for 2 periods of ex-
posure (3 and 24 h). Complete/serum-freemedia were used as negative
control and MMS 100 μM in complete/serum-free mediumwas used as
positive control. After treatment, the cells were washed with PBS and
detached with trypsin 0.25% for 1 min, which was then inactivated
with complete medium. The content of each well was collected into a
microtube and centrifuged for 3 min at 7500 ×g (for three times).
After the ﬁrst centrifugation the pellet was suspended in PBS. After
the second centrifugation, the cell density of 2.5 × 104 cell/mL was cal-
culated and transferred to another microtube for the ﬁnal
centrifugation.
2.6. Interference studies of nanomaterials with cytotoxic assays
To reveal possible interferences of nanomaterials with cytotoxicity
assays experimental procedures, two main sets of experiments were
conducted: (1) to analyse the effect of materials presence on optical
measurements (light-absorption interference) and (2) to assess possi-
ble nanomaterials reactivity with assay components (catalytic interfer-
ence). For the LDH assay, an additional experiment was carried out to
understand the possible interference of nanomaterials on the enzymatic
activity of LDH. All sets of experiments were carried out in the absence
of cells; the three highest concentrations of each material were tested
(25, 100 and 300 μg/mL for TiO2 NPs; 0, 225, 900 and 2700 μg/mL for
NK clay and 250, 1000 and 3000 μg/mL for C-TiO2 nanocomposite)
and complete/serum-free media was used as negative control.
2.6.1. Light-absorption interference.
For MTT reduction and neutral red uptake (NRU) assays, light ab-
sorption interference was analysed in the presence of dissolving solu-
tions (DMSO and ﬁxative solution, for MTT and NRU assay,
respectively) and reaction end-products (formazan dissolved in DMSO
and neutral red dissolved in ﬁxative solution) as previously suggested
by Kroll et al. (2012). End-products were obtained by incubating live
cells withMTT andNRU dyes. The nanomaterials suspensionswere pre-
pared in dissolving solutions and end-products at the concentrations
mentioned above. In turn, for the alamar blue (AB) assay, the
nanomaterials suspensions were prepared in both resazurin and its
pink-coloured reduced form resoruﬁn obtained by reaction with formic
acid.
The interference of nanomaterials presence in optical detection of
INT reduction during the LDH assay was performed using oxidized
and reduced INT. The reduced INT was obtained by adding 2-
mercaptoethanol until obtain a red colour. Total reduction of INT was
veriﬁed as previously described by Kroll et al. (2012).
Absorbancewasmeasured at 570 nm and 540 nm for MTT and NRU,
respectively, at 570 nm with a reference wavelength of 630 nm for the
AB assay, and at 490 nm with a reference wavelength of 655 nm for
the LDH assay using a Cambrex ELx808microplate reader (Biotek, KC4).
2.6.2. Catalytic interference.
Nanomaterials reactivity with dyes was determined by incubating
100 μL of nanomaterials suspensions prepared in complete and
serum-freemediawithMTT, NRU andAB assays reagents in the absence
of cells (4 h of incubation for MTT and AB, and 3 h for NRU). The absor-
bance was measured at the end of the incubation.
In case of LDH assay, positive control wells with only 100mUof LDH
were also included. The assay was carried according to the kit
manufacturer's instructions (Cytotoxicity Detection Kit LDH, Cat. no.
11644793001, Roche Diagnostics Corp). As previously described by
Kroll et al. (2012), light absorption was measured continuously at490 nm with a reference wavelength of 655 nm using a Cambrex
ELx808 microplate reader (Biotek, KC4) for 1 h at 37 °C.
2.6.3. Enzymatic interference (LDH activity).
For the LDH assay, an additional experiment was carried out to un-
derstand the possible interference of nanomaterials on the enzymatic
activity of LDH, by either inactivating or adsorbing the LDH protein
based on Ahmad et al. (2012), Kroll et al. (2012) and Holder et al.
(2012). For each nanomaterial concentration different amounts of
LDH (20, 50, 100 and 500 mU) were tested in a 96-well plate and four
periods of exposure were assessed (15 min, 60 min, 3 and 24 h). After
these time periods, 100 μL of the kit reaction buffer was added and the
remaining assaywas carried according to the kitmanufacturer's instruc-
tions (Cytotoxicity Detection Kit LDH, Cat. no. 11644793001, Roche Di-
agnostics Corp). Spectrophotometric absorption was taken at 490 nm
with a reference wavelength of 655 nmusing a Cambrex ELx808micro-
plate reader (Biotek, KC4).
2.7. Cytotoxicity assays
At the end of the exposure period, the treatment was removed and
100 μL of MTT or AB reagent, prepared in serum-free medium
(0.5 mg/mL and 20 μg/mL, respectively), were added to each well and
incubated for 4 h at 37 °C in the dark. Regarding theMTT assay, after re-
moving the MTT, the produced formazan was solubilized with 200 μL
DMSO. Thereafter, the plates were centrifuged (Universal 320, Hettich)
at 4000×g for 10min and 100 μL of the supernatant were transferred to
a new plate for the ﬁnal reading. Spectrophotometric absorbance was
measured at 570 nm for MTT and at 570 nm with a reference wave-




To evaluate the possible interactions of nanomaterials with alkaline
comet assay, a lysis test was performed. This involved the addition of
100 μL of nanomaterials at the highest tested concentrations to an
equal volume of cells suspended in 1.2% LMP agarose just before run-
ning the assay. The assay was then performed as described below in
Section 2.8.2. Results obtained for each type of media (complete or
serum-free) and each type of nanomaterial (TiO2 NPs, NK or C-TiO2)
were compared with a negative control (cells without nanomaterials).
2.8.2. Alkaline comet assay.
Cells were embedded in 200 μL of 0.6% LMP agarose and 5 μL drops
were placed on microscope slides precoated with 1% NMP (the tech-
nique was carried out using a medium throughput system 12 gel
comet assay unit, Severn Biotech Ltd.®). After agarose solidiﬁcation,
the slides were placed in a coplin jar and immersed in lysis solution
(NaCl 2.5 M, Na2EDTA 100 mM, Tris-base 10 mM, NaOH 10 M, pH 10,
Triton-X 100 1%) during 1 h. For unwinding of DNA, all slides were im-
mersed in electrophoresis solution (Na2EDTA 1 mM, and NaOH 0.3 M,
pH 13) in the electrophoresis platform for 40 min, followed by electro-
phoresis for 20 min (1.15 V/cm). Slides were then transferred to cold
PBS (pH 7.2) for 10 min and cold deionized water for 10 min. Slides
were ﬁxed with ethanol 70% and 96% for 15 min each at room temper-
ature and gels were dried overnight. Slides were stained with
SyberGold® in TE buffer (Tris-HCl 10 mM and EDTA 1 mM) and visual-
ized in a Nikon Eclipse E400 microscope with an epi-ﬂuorescence at-
tachment and 250× magniﬁcation. Slides were analysed using the
Comet Assay IV Software (Perceptive Instruments). At least 100 cells
were scored (50 for each replicate gel). The percentage of DNA in the
comet tail (% tDNA) was used as DNA damage parameter.
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Statistical analysiswasperformed using SPSS forWindows statistical
package (version 23.0). The continuous data from cell viability and the
comet assay were tested for normality using the Kolmogorov-Smirnov
test. Since it was not normally distributed, different mathematically
transformations were attempted but normal distribution and variance
homogeneity (tested with Levene's test) was only possible for comet
assay data.
Therefore, cytotoxicity data was analysed using the non-parametric
Jonckheere-terpstra test to examine possible trends along the tested
concentrations. Comet assay data was analysed after data transforma-
tion (using ln function) using one-way ANOVA with Dunnet's test for
pairwise comparisons and linear regression for trend analysis.
Whenever a statistical signiﬁcant trend was found, a curve ﬁr analysis
was also performed using polynomial regression.
For all experimental conditions tested, aminimumof three indepen-
dent experiments were performed (in viability assays, each performed
in triplicate). Experimental data were expressed as mean ± standard
error and a P-value b 0.05 was considered signiﬁcant.
3. Results
3.1. Nanomaterial characterization
Rutile TiO2 NPswere found to be nearly spherical agglomerates with
different particle size. The primary particle of TiO2 NPswasmainly elon-
gated and rounded, suggesting an ellipsoidal, rod-like 3D structure with
b50 nm long. TiO2 NPswere highly agglomerated. RegardingNK clay, its
FE-SEM analysis showed irregular laminar particles having 0.1 to 1.4 μm
in length and b100 nm in thickness. NK particles were agglomerated in
spherical particles due to the spray drying procedure followed after pu-
riﬁcation of clay. Despite remaining spherical agglomerates of the
nanoclay, the C-TiO2 nanocomposites exhibited irregular laminar type
shape, characteristic of the mayor clay component (Fig. S1).
Table 1 summarizes the main physico-chemical properties of the
nanomaterials suspended in water, serum-free and complete media,
namely hydrodynamic size, dispersity and zeta-potential. In all aqueous
suspensions, TiO2 NPs exhibited the smallest hydrodynamic size, when
compared to the remaining materials while C-TiO2 nanocomposite
presented higher size than TiO2 NPs and NK clay (with exception in
the serum-free medium). In addition, C-TiO2 tended to agglomerate
more extensively in water than in either biological media, presenting
the size of 7289 nm and a polydisperse index of 1; this means that the
C-TiO2 suspension is non-uniform in water. When in cell culture
media, C-TiO2 presented larger size in serum-free medium (2419 nm)
than in complete medium (470 nm); however, dispersity was very
similar for both media. Similarly to the nanocomposite, both TiO2 NPs
and NK presented higher hydrodynamic sizes in serum-free than in
complete media.Table 1
Physicochemical description of studied nanomaterials (TiO2 NPs, NK clay and C-TiO2).
DLS
Average hydrodynamic si
TiO2 NPs H2Oa 196.7
HepG2 serum-free mediuma 447.2
HepG2 complete mediuma 236.6
NK H2Oa 508.4
HepG2 serum-free mediuma 2675.0
HepG2 complete mediuma 447.5
C-TiO2 H2Oa 7289.0
HepG2 serum-free mediuma 2419.0
HepG2 complete mediuma 470.0
DLS: dynamic light scattering; LDV: laser Doppler velocimetry.
a All materials were tested at 0.01 μg/mL.
b Media components did not allowed a correct assessment of the ζ – potential of materials.Regarding measurements of zeta potential in water, the TiO2 NPs
showed the largest absolute value (ζ – potential of 41.6) and, therefore,
was found to be themost stable suspension,while the C-TiO2 nanocom-
posite was the least stable (ζ – potential of 10.4).
3.2. Nanomaterial interferences with in vitro cytotoxicity assays
Table 2 represents the main interferences observed in the present
study. Light-absorption interferences studies intended to analyse the in-
ﬂuence of materials presence on absorbance measurements while cata-
lytic interferences addresses possible nanomaterials reactivity with
assay components. For the LDH assay, an additional experiment was
conducted, evaluating the interference of nanomaterials on LDH enzy-
matic activity.
The results obtained showed that all tested materials, regard-
less of the presence or absence of serum, did interfere with
absorbance measurements, both in presence of the substrate and
ﬁnal products of each assay introducing bias in the ﬁnal result;
one exception was observed for TiO2 NPs in the LDH membrane in-
tegrity assay. To obviate this interference due to nanomaterial
presence in assay reading, the plates were centrifuged before
absorbance measurements. This procedure was enough to elimi-
nate optical interference of these nanomaterials for MTT, AB and
NRU assays since, after centrifugation, the absorbance obtained
was similar to those obtained in negative controls (data not
shown). However, for LDH assay, the centrifugation was not
enough to eliminate the NK and C-TiO2 light interference, as a
decrease in absorbance was still observed with the increase in
nanomaterial concentrations (data not shown).
Regarding the nanomaterials reactivity with the assay compo-
nents, all nanomaterials concentrations exhibited a similar signal
compared to negative controls for the MTT, AB and LDH assays
in both media, which ruled out catalytic interferences from
nanomaterials under evaluation. In opposition, during NRU assay,
the NK clay and C-TiO2 nanocomposite could react with the NRU
assays components, possibly by adsorption, leading to a signiﬁcant
decrease in absorbance signal.
Since LDH is an enzymatic assay, it was also evaluated if studied
nanomaterials could inactivate or adsorb LDH protein present in the
supernatant, which would decrease the ﬁnal measured absorbance. In
the absence of serumproteins, all nanomaterialswere found to interfere
with enzymatic activity of LDH over time, decreasing the ﬁnal absor-
bance values.
The results obtained herein suggest that NK clay and C-TiO2
nanocomposites were able to signiﬁcantly interfere with NRU and
LDH assay components, decreasing the signal in both assays. As these
interferences could not be eliminated by protocol alterations, only
MTT and AB assays were found to be suitable for further in vitro
cytotoxicity studies after inclusion of a centrifugation step. In this way,
we were able to assure that in the presence of cells there would be noLDV











Interference of the nanomaterial, suspended in serum-free (SFM) and complete (CM)
media, with in vitro toxicity test systems (MTT, AB, NRU and LDH assays).
TiO2 NPs NK clay C-TiO2
SFM/CM SFM/CM SFM/CM
MTT Optical +/+ +/+ +/+
Catalytic −/− −/− −/−
AB Optical +/+ +/+ +/+
Catalytic −/− −/− −/−
NRU Optical +/+ +/+ +/+
Catalytic −/− +/+ +/+
LDH Optical −/− +/+ +/+
Catalytic −/− −/− −/−
Enzymatic +/− +/− +/−
+: interference detected.
−: no interference detected.
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cles and therefore results obtained would not be biased by the
nanoparticle presence but would be due to nanoparticle effect on cell
function.
3.3. In vitro cytotoxicity
Regarding the cellular viability analysis using the MTT assay (Fig. 1),
in serum-free medium, TiO2 NPs induced a signiﬁcant concentration-
dependent decrease in viability of the liver cells only after 24 h of
exposure to these nanoparticles (P = 0.011) in serum-free medium,
while NK clay and C-TiO2 nanocomposite induced a signiﬁcant
concentration-dependent decrease in viability of HepG2 cells, in all
studied exposure periods. In completemedium, a signiﬁcant concentra-
tion-dependent decrease in viability of HepG2 cells was observed in all
studied periods of exposure and all materials with exception to 6 h of
exposure to NK although in this case, P value was near to signiﬁcance
value (data not shown) (Fig. 1).
The results of cellular viability assessed by the AB assay (Fig. 2),
were found to be similar to the ones obtained in the MTT assay inFig. 1. Cell viability of the HepG2 cell line after exposure to TiO2 NPs, NK clay and C-TiO2 nano
normalized considering negative control as 100%. P value b 0.05 signiﬁcance difference after trserum-free medium: TiO2 NPs induced a signiﬁcant concentration-
dependent decrease in HepG2 viability only after 24 h (P b 0.001),
while NK clay and C-TiO2 nanocomposite lowered the cell viability
for all periods of exposure in a concentration-dependent way. In
complete medium, TiO2 NPs exhibited a decrease in the HepG2
cell viability for the 3 and 6 h of exposure; for the 24 h period, it
was not observed a statistically signiﬁcant trend, possibly due to
the increase in cell viability observed at 100 μg/mL concentration
point.
Once againNK and C-TiO2 nanomaterials presented similar results to
MTT results (despite for 3 h the C-TiO2 did not present a signiﬁcance
value).
3.4. Nanomaterial interferences with alkaline comet assay
Literature describes a mechanism involved in nanomaterials
interference with alkaline comet assay, which includes association
to nucleoid DNA, affecting its behaviour during electrophoresis and
inducing breakings in the naked DNA. Therefore, during the lysis
step of the comet assay, nanomaterials may interact with the
unprotected DNA and cause additional DNA damage, interfering
with the sensitivity of the assay, thus misleading the results
(Karlsson, 2010; Magdolenova et al., 2012).
In serum-free media all nanomaterials seemed to cause addition-
al DNA damage, interfering with the assay. Conversely, there were no
signiﬁcant differences between the lysis test of all materials and the
negative control in the presence of serum proteins, showing that
tested nanomaterials did not interfere with the alkaline comet
assay (data not shown). To eliminate interferences observed in
serum-free medium, extensive washing of the wells was performed
after the nanomaterials exposure (just before performing the
alkaline comet assay), in order to remove nanomaterials.
3.5. In vitro genotoxicity
In the absence of serum proteins it was observed a signiﬁcant
increase in DNA damage only after 3 h of exposure to TiO2 NPsmaterials assessed by MTT viability assay in serum-free and complete media. Values were
end analysis using the Jonckheere-Terpstra test. PC: positive control (Triton X-100 1%).
Fig. 2. Cell viability of the HepG2 cell line after exposure to TiO2 NPs, NK clay and C-TiO2 nanomaterials assessed by AB viability assay in serum-free and complete media. Values were
normalized considering negative control as 100%. P value b 0.05 signiﬁcance difference after trend analysis using the Jonckheere-Terpstra test. PC: positive control (Triton X-100 1%).
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the presence of serum proteins, i.e., it was observed DNA damage only
after longer periods of exposure (24 h).
Concerning NK and C-TiO2 nanomaterials, it was observed that both
materials presented a similar impact on DNA integrity in each of the
studied cell culturemedia. These nanomaterials could induce signiﬁcant
single strand breaks and alkali-labile sites on the HepG2 DNA only after
3 h of exposure in complete medium (Fig. 3).Fig. 3. Genotoxicity of TiO2 NPs, NK clay and C-TiO2 nanomaterials on HepG2 cells analysed b
analysis with single pair-wise Dunnet's test and R2 coefﬁcient of determination after curve ﬁt w4. Discussion
One of the main concerns of nanotechnology applications is that
nanoparticles may be more toxic, and therefore more hazardous than
larger particles and bulk materials, due to their large surface area and
consequent enhanced chemical reactivity and also cellular internaliza-
tion (Tucci et al., 2013). In the past years, TiO2 NPs have been extensive-
ly studied to investigate their potential toxicological effects due to theiry alkaline comet assay in serum-free and complete media. P b 0.05 signiﬁcant value after
ith polynomial regression. *P value b 0.05. PC: positive control (MMS 100 μM).
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In order tomonitor and control the release of TiO2 NPs, the technique of
immobilization of these nanoparticles into crystalline substrates, such
as inorganic clay minerals, was developed to facilitate their manipula-
tion, restraining their release and diminishing their threat into the envi-
ronment and human health (MODENA, 2012; Tokarsky et al., 2012;
Tokarčíková et al., 2014).
The present study measured the cellular interaction and biologi-
cal responses of human hepatocytes after exposure to TiO2 NPs
immobilized in NK clay laminar structures after characterization of
these nanomaterials.
Our results suggest that the absence of serum leads to an increase in
the agglomeration state, i.e., serum proteins allow a better dispersion
of thesematerials.When attempting to performzeta potentialmeasure-
ments, it was found that the ionic strength of medium impacted mea-
surement reproducibility since the high salt content would interfere
with the electrodes in the capillary tube. Additionally, in the presence
of FBS, a very broad distribution of charges with a peak close to 0 mV
was found due to the wide distribution of charges from both particles
and proteins as observed in previous studies (Murdock et al., 2008).
To achieve the main goal of the present work, a set of experiments
was performed in order to assess cellular viability and DNA damage
on hepatic cells. In addition, all proposed assays were tested in regards
to possible interference of studied nanomaterials with optical, catalytic
and even enzymatic performance. Only the MTT and AB assays were
found to be suitable for cytotoxicity assessment; while MTT allows the
detection of mitochondrial activity (Kroll et al., 2009), AB is an indicator
of the redox potential of cells (Takhar and Mahant, 2011). Both NK clay
and C-TiO2 nanocomposite exhibited light and catalytic interferences
for NRU assay regardless the presence of serum, while all materials in-
terfered with LDH enzymatic activity when suspended in serum-free
medium. Possibly, LDH proteins were adsorbed to materials surface
and ceased to be able to reduce the INT compound. This would trigger
false negatives, i.e., the assaywould indicate that the integrity of the cel-
lular membrane was maintained when, in reality, the LDH was simply
not available to convert lactate to pyruvate due to nanomaterials
adsorption. Such an effect was not observed in complete medium
(with FBS proteins), possibly due to the presence of a protein corona
formed by the FBS proteins around the materials, which avoided LDH
adsorption. These results were in accordance with some previous inter-
ferences studies in different metal nanoparticles, with special emphasis
on TiO2 NPs, which also demonstrated that LDH could be adsorbed and
even get inactivated by these nanomaterials (Ahmad et al., 2012;
Guadagnini et al., 2013).
Actually, there are reports that already indicate that metal oxide
nanoparticles interact with assay components or dyes or even with op-
tical readouts due to high adsorption or scattering by nanoparticles,
distorting the assay outcome on the viability assessment (Kroll et al.,
2012). A recent work reported that TiO2 NPs could interfere with the
NRU assay, increasing the signal reading for these dyes, which could
be related to the light-absorbing properties of this nanoparticle
(Guadagnini et al., 2013). Notwithstanding this, the signal in the pres-
ence of NK and C-TiO2 was found to be lower in the NRU assay for our
current study, which could indicate that these nanomaterials could
reacted with the NRU assay components, possibly adsorbing to them.
This would decrease the signal with increase of material concentration,
misleading the results. In respect of NK or even C-TiO2, no interference
studies regarding the toxicity assays have been made so far.
Iavicoli et al. (2011) reviewed studies on the cytotoxicity of TiO2 NPs,
but only few reported analyses of rutile TiO2 NPs effects on hepatic cell
lines. According to literature, TiO2 NPs rutile:anatase can induce in vitro
cytotoxicity on hepatic cells after long periods and high doses of expo-
sure. For instance, Gaiser et al. (2013) found no cytotoxic on C3A hepa-
tocytes after exposure to rutile with minor anatase TiO2 NPs up to high
doses (approximately 2000 μg/mL), using the AB and LDH assays. These
results were consistent with the ones obtained by Kermanizadeh et al.(2013) for the same cell line and using exclusively mitochondrial activ-
ity assays. With respect to studies performed on HepG2 cell line, Prasad
et al. (2014) demonstrated that TiO2 NPs (mainly constituted with ana-
tase) did not induce a signiﬁcant decrease in cell viability in the pres-
ence of FBS, at concentrations below 100 μg/mL even after 24 h of
exposure. Furthermore, Shukla et al. (2013) found only a negligible
loss of HepG2 viability after 6 h of exposure while, for longer time pe-
riods (24 and 48 h), concentrations of 20 to 80 μg/mL induced a signif-
icant decrease on viability of approximately 20%, assessed with MTT
andNRU assays. In opposition to those results, our rutile TiO2 NPs exhib-
ited adverse effects on the hepatocytes mitochondrial activity for short
exposure periods in complete medium, shown by the decreased viabil-
ity observed in the MTT assay.
In the present work, rutile TiO2 NPs induced an increase on DNA
damage of HepG2 cells only for the shortest periods of exposure (3 h)
in incomplete medium; the lack of effect observed for longer
periods of exposure (24 h) may be due to DNA repair or diminished
nanoparticle internalization associated to agglomeration phenomena
(nanomaterials internalizations results are not shown). In complete
medium, higher levels of DNA damage were observed after 24 h of ex-
posure, suggesting that for shorter periods of exposure, the presence
of serum proteins may protect DNA from TiO2 NPs effect. According to
the Nanogenotox project report, which evaluated the genotoxicity of
different TiO2 NPs from the JRC repository in different cell lines (BEAS
2B, 16 HBE, A549, Caco-2 and NHEK), the NM-104 TiO2 NPs studied
here only caused DNA damage on the dermal cell line NHEK, again
after 3 and 24 h of exposure; however, for the same concentrations test-
ed in the present work, in the NHEK cell line there were not found any
signiﬁcant DNA damage (Norppa et al., 2013). Different projects study-
ing rutile and anatase TiO2NPs concluded that anatase TiO2NPs induced
more extensive DNA damage than the rutile ones in HepG2 cell line
(Petković et al., 2011). This has led to some authors to suggest that rutile
TiO2 NPs could be considered as negative controls in nanotoxicological
studies (Liu et al., 2013), which is not supported by our results.
Despite the multiple functionalities of the clay minerals, the use of
nanoclays still raises concerns due to the little information available
about the toxicity that these nanomaterials can induce (Maisanaba et
al., 2015). Herein, the NK mineral induced a signiﬁcant concentration-
dependent decrease in the viability of HepG2 cells for all periods of
exposure and media types (with exception of the 6 h treatment in
complete medium for both assays). According to our knowledge, no
previous studies on HepG2 cell have previously been made with this
type of clay and there are still few toxicological studies in the literature
about clays with this hepatic cell line (Abdel-Wahhab et al., 2015).
Different cytotoxicity studies using clays demonstrated that these
minerals are able to cause cytotoxicity in different cell lines, and even
induce cell death (Maisanaba et al., 2015). Some studies show that
several clays induce cytotoxicity only at high concentrations (Han et
al., 2011) while others describe signiﬁcant loss of cellular viability at
lower concentrations (Lordan et al., 2011; Verma et al., 2012;
Maisanaba et al., 2014).
Regarding the C-TiO2 nanocomposite, the results observed in the
comet assay were found to be similar to the ones obtained for NK
clay: higher levels of DNA damage were observed only after shorter
periods of exposure (3 h) in complete medium possibly due to
diminished nanoparticle internalization at 24 h (nanomaterials
internalizations results are not shown). The exact same effect was
observed in both materials, probably because C-TiO2 nanocomposite is
mainly constituted by NK clay. When comparing results obtained in
complete and incomplete media, it seems that the presence of serum
proteins promotes the internalization of both NK clay and C-TiO2 nano-
composite (data not shown),which can possibly be related to the capac-
ity of these materials to interact with HepG2 DNA, causing further
damage. The interaction of nanomaterials with serum proteins is often
related with the formation of a protein corona that, in some cases, is
associated with cell uptake. Once inside the cells, nanomaterials may
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of reactive oxygen species, possibly leading to DNA damage (Albanese
et al., 2012). Other authors studying genotoxicity of different type of
clays also observed DNA strand breaks on hepatic HepG2 cells in a
time dependent manner, which is further conﬁrmed by comet assay
(Maisanaba et al., 2013; Houtman et al., 2014).
Altogether, results suggest that NK clay has the largest contribution
to the cytotoxicity and genotoxicity of C-TiO2 nanocomposites. Possible
synergistic or additive effects between the studied materials are not
discussed as our study design is not themost appropriate to understand
the real interactions that may occur. Thereby, NK clay is not a suitable
clay substrate for the immobilization of other nanomaterials (for
instance the TiO2 NPs), since increased concentrations of NK induce a
signiﬁcant decrease in the cell viability in the HepG2 cell line, which
was also observed on the C-TiO2 nanocomposites. A possible strategy
to overcome the cytotoxic and genotoxic effects of naked kaolinite
observed in this study is to chemically modify NK clay with organic
compounds (Maisanaba et al., 2014). These data underline that further
toxicity studies must be performed in organoclay particles to under-
stand if the chemical modiﬁcation allows the creation of a more
compatible NK clay.
5. Conclusions
Both cytotoxic and genotoxic effects were observed on the HepG2
hepatic cell line after exposure to C-TiO2 nanocomposites and its single
elements. Results here obtained conﬁrm that TiO2 nanoparticles present
toxicity to HepG2 cells and that the immobilization of these nanoparti-
cles in NK clay substract is not enough to diminish its toxicity. In fact,we
could observe that NK clay is also responsible for cytotoxic and
genotoxic effects in the studied hepatic cell line being themajor contrib-
utor for the toxicity found also for the nanocomposite. Taking all into
account, thepresent study suggests that NK clay is not a suitablemineral
substrate for the immobilization of other nanomaterials.
The current innovative study represents a primordial toxicity
evaluation of the nanocomposites using mineral nanoclay structures
to tame NPs toxicity on environmental and human exposure, moving
towards to a safer application of these new materials.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2016.12.018.
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